Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Association between the initial blood lactate level and prognosis in patients with stroke treated with intravenous thrombolysis

Fettah Eren, Aysegul Demir, Gullu Eren.




Abstract
Cited by 0 Articles

Aim: Decreased oxygen in cerebral tissues induces anaerobic glycolysis and lactate production increases. It has been demonstrated that blood lactate level is an independent risk factor for poor outcome in patients with acute ischemic stroke (AIS). In this study, the association between initial blood lactate level and short-term prognosis in patients with AIS treated with intravenous thrombolysis was evaluated.
Materials and Methods: Three hundred and sixty one patients treated with intravenous thrombolytic treatment (IVT) were included in the study. Initial symptoms, comorbid diseases and localization of ischemia were recorded. Blood samples were obtained after stroke symptoms within 4.5 hours. Lactate levels were tested before IVT. Disability was calculated with National Institutes of Health Stroke Scale (NIHSS). At 24th and 72th hours, cerebral hemorrhagic transformation was evaluated with brain computed tomography. In-hospital mortality rate was determined. Patients were divided into 2 groups according to difference of NIHSS score (clinical improvement=NIHSS score decreased 4 points or more and no clinical improvement=other patients). Patients were divided into 2 groups according to lactate levels (low=lactate ≤2 mmol/L and high=lactate> 2 mmol/L).
Results: A total of 361 patients, 188 (52.1%) female and 173 (47.9%) male were included in the study. Lactate level and base excess (BE) were higher in patients with severe disability (p

Key words: Intravenous thrombolysis; ischemic stroke; lactate; prognosis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.